Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients

OBJECTIVE: This study aims to analyze whether there are any differences in clinicopathological features and prognosis between HER2 ultra-low, HER2-null, and HER2-low expression in Chinese breast cancer (BC) patients. METHODS: The clinicopathological data of 1363 HER2-negative BC patients were retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhaoxu, Jia, Huiqing, Zhang, Huina, Chen, Lifang, Zhao, Peng, Zhao, Jing, Fu, Guangming, Xing, Xiaoming, Li, Yujun, Wang, Chengqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505593/
https://www.ncbi.nlm.nih.gov/pubmed/37639064
http://dx.doi.org/10.1007/s10549-023-07079-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505593/
https://www.ncbi.nlm.nih.gov/pubmed/37639064
http://dx.doi.org/10.1007/s10549-023-07079-8

Ejemplares similares